Advancing vaccine development for African swine fever

Within the Horizon Europe Framework Programme, a funding opportunity is open to support research and innovation in reducing the burden of African swine fever (ASF), and thus contributing to a safeguarding animal health and the economic resilience of the sustainable livestock industry.

Activities under this topic will contribute to the following expected outcomes:

• Improved capacity to develop ASF pilot vaccines and their companion DIVA tests for the possible prevention and/or eradication of the disease in domestic pigs and wild boars;
• Vaccination strategies for both wild boar and domestic pigs, addressing different objectives and needs (e.g. eradication in wild boar; emergency or preventive use in domestic pigs).
• Increased international cooperation on a possible ASF vaccine.

Proposals should ensure adequate involvement of stakeholders from the European Medicines Agency, veterinary authorities, farmers and hunters. Involvement of the pharmaceutical industry is highly recommended.

For more information on Admissibility conditions and Eligible countries, visit https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-cl6-2023-farm2fork-01-5;callCode=HORIZON-CL6-2023-FARM2FORK-01;freeTextSearchKeyword=;matchWholeText=true;typeCodes=0,1,2,8;statusCodes=31094501,31094502;programmePeriod=2021%20-%202027;programCcm2Id=43108390;programDivisionCode=43121563;focusAreaCode=null;destinationGroup=45355322;missionGroup=null;geographicalZonesCode=null;programmeDivisionProspect=null;startDateLte=null;startDateGte=null;crossCuttingPriorityCode=null;cpvCode=null;performanceOfDelivery=null;sortQuery=sortStatus;orderBy=asc;onlyTenders=false;topicListKey=topicSearchTablePageState